RE:RE:ValueExpire, I believe you to be correct in that there have been no advanced studies on other forms of cancer. I also believe you to be correct in suggeting that MCNA will more likely than not be effective on other cancers under the right trial protocol, Where I differ with you is the suggestion that the share price hinges on approval. There is no hinge. The share prices trades with somewhere between a 70% and 80% projection of failure in the BLA submission. I think that the probability of success in this submission is somewhere in that range. However the powers that choose to be have some level of comfort allowing the stock to trade with a heavy probability of rejection. I would have no idea why this is the case( financing for friends perhaps?), but this is quite clearly the way they choose it to be perceived.